We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+31.27%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.91B
AUM Growth
+$590M
Cap. Flow
+$43.3M
Cap. Flow %
1.11%
Top 10 Hldgs %
41.55%
Holding
108
New
10
Increased
23
Reduced
13
Closed
15

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$49.2M
2
CRM icon
Salesforce
CRM
+$31.6M
3
RNAM
Avidity Biosciences
RNAM
+$30.3M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$28.2M
5
FERG icon
Ferguson
FERG
+$26.4M

Top Sells

Rank Stock Value
1
ETNB
89bio
ETNB
+$60.4M
2
GEHC icon
GE HealthCare
GEHC
+$39.4M
3
DKS icon
Dick's Sporting Goods
DKS
+$28.8M
4
DDOG icon
Datadog
DDOG
+$24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$16.7M

Sector Composition

Rank Sector Weight
1 Healthcare 51.02%
2 Technology 11.4%
3 Consumer Discretionary 5.04%
4 Financials 4.79%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$533M 13.64%
800,000
+100,000
+14% +$64.1M
ARQT icon
2
Arcutis Biotherapeutics
ARQT
$3.42B
$198M 5.06%
10,478,000
-1,057,582
-9% -$16.7M
BNTC icon
3
Benitec Biopharma
BNTC
$394M
$139M 3.55%
9,876,506
– –
META icon
4
Meta Platforms (Facebook)
META
$1.51T
$126M 3.21%
170,973
+1,128
+0.7% +$840K
LEGN icon
5
Legend Biotech
LEGN
$4.3B
$125M 3.19%
3,818,009
+44,000
+1% +$1.62M
ETNB
6
DELISTED
89bio
ETNB
$122M 3.12%
8,280,000
-5,930,000
-42% -$60.4M
IMTX icon
7
Immatics
IMTX
$1.24B
$102M 2.62%
12,030,129
– –
KO icon
8
Coca-Cola
KO
$354B
$96.5M 2.47%
1,455,080
+221,850
+18% +$15.3M
GE icon
9
GE Aerospace
GE
$367B
$93.3M 2.39%
310,262
– –
NVDA icon
10
NVIDIA
NVDA
$5.01T
$90.2M 2.31%
483,535
-16,027
-3% -$2.79M
EYPT icon
11
EyePoint Inc
EYPT
$1.02B
$88.2M 2.26%
6,192,715
-611,376
-9% -$7.04M
BHVN icon
12
Biohaven
BHVN
$2.16B
$84.4M 2.16%
5,620,271
– –
MLYS icon
13
Mineralys Therapeutics
MLYS
$2.35B
$80.9M 2.07%
2,132,133
+387,641
+22% +$8.38M
HD icon
14
Home Depot
HD
$332B
$79.9M 2.05%
197,311
+66,590
+51% +$26.2M
TSM icon
15
TSMC
TSM
$2.09T
$77.4M 1.98%
277,201
-23,200
-8% -$5.67M
KURA icon
16
Kura Oncology
KURA
$922M
$71.8M 1.84%
8,116,000
– –
FERG icon
17
Ferguson
FERG
$44.7B
$68.8M 1.76%
306,260
+116,600
+61% +$26.4M
AVBP icon
18
ArriVent BioPharma
AVBP
$1.48B
$68.3M 1.75%
3,703,452
+290,664
+9% +$5.71M
APLS
19
DELISTED
Apellis Pharmaceuticals
APLS
$65.1M 1.67%
2,878,000
– –
AMD icon
20
Advanced Micro Devices
AMD
$851B
$64.5M 1.65%
398,799
– –
ORCL icon
21
Oracle
ORCL
$331B
$63.6M 1.63%
226,318
-4,410
-2% -$1.12M
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$2.65B
$60.7M 1.55%
2,019,000
-259,000
-11% -$7.77M
BAC icon
23
Bank of America
BAC
$435B
$59.9M 1.53%
1,160,330
+233,140
+25% +$11.4M
KALV
24
DELISTED
KalVista Pharmaceuticals
KALV
$58.1M 1.49%
4,768,712
-186,288
-4% -$2.57M
APO icon
25
Apollo Global Management
APO
$70.7B
$57.5M 1.47%
431,260
+2,800
+0.7% +$396K
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return

Suvretta Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Suvretta Capital Management held 108 positions worth $3.91B, up 18% from $3.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management's Q3 2025 filing shows 10 new, 23 increased, 13 reduced and 15 closed positions. Its largest new stake was Keurig Dr Pepper: 1,570,000 shares worth $40.1M. The largest sale was 89bio, an estimated $60.4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Suvretta Capital Management's largest Q3 2025 buy was Keurig Dr Pepper: 1,570,000 shares worth $40.1M.
  • Suvretta Capital Management added most to Ferguson in Q3 2025, an estimated $26.4M increase.
  • Suvretta Capital Management's biggest Q3 2025 reduction was 89bio, cutting an estimated $60.4M.
  • Suvretta Capital Management fully exited GE HealthCare in Q3 2025, selling an estimated $39.4M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.91B portfolio in Q3 2025.
  • Suvretta Capital Management opened 10 new positions and closed 15 in Q3 2025.
  • Suvretta Capital Management's portfolio value rose 18% quarter-over-quarter to $3.91B.

Based on Suvretta Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.